A Reappraisal of the Diagnostic Performance of B-Mode Ultrasonography for Mild Liver Steatosis
- PMID: 36305695
- DOI: 10.14309/ajg.0000000000002020
A Reappraisal of the Diagnostic Performance of B-Mode Ultrasonography for Mild Liver Steatosis
Abstract
Introduction: Previous studies have shown that ultrasonography has high specificity (80%-100%) but low sensitivity (50%-70%) in diagnosing fatty liver; sensitivity is especially low for mild steatosis. In this study, we aimed to reappraise the diagnostic performance of B-mode ultrasonography (B-USG) for fatty liver disease.
Methods: We performed a retrospective, multinational, multicenter, cross-sectional, observational study (6 referral centers from 3 nations). We included 5,056 participants who underwent both B-USG and magnetic resonance proton density fat fraction (MRI-PDFF) within a 6-month period. The diagnostic performance of B-USG was compared with that of MRI-PDFF as a reference standard for fatty liver diagnosis, using sensitivity, specificity, positive and negative predictive values, diagnostic accuracy, and area under the receiver operating characteristic curve (AUC).
Results: B-USG showed a sensitivity of 83.4%, specificity of 81.0%, and AUC of 0.822 in diagnosing mild liver steatosis (6.5% ≤MRI-PDFF ≤14%). The sensitivity, specificity, and AUC in diagnosing the presence of fatty liver disease (MRI-PDFF ≥6.5%) were 83.4%, 81.0%, and 0.822, respectively. The mean PDFF of B-USG-diagnosed nonfatty liver differed significantly from that of diagnosed mild liver steatosis (3.5% ± 2.8% vs 8.5% ± 5.0%, P < 0.001). The interinstitutional variability of B-USG in diagnosing fatty liver was similar in diagnostic accuracy among the 6 centers (range, 82.8%-88.6%, P = 0.416).
Discussion: B-USG was an effective, objective method to detect mild liver steatosis using MRI-PDFF as comparison, regardless of the etiologies and comorbidities.
Copyright © 2022 by The American College of Gastroenterology.
Similar articles
-
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study.J Gastroenterol. 2024 Jun;59(6):504-514. doi: 10.1007/s00535-024-02096-w. Epub 2024 Mar 30. J Gastroenterol. 2024. PMID: 38553657 Free PMC article.
-
Discordance diagnosis between B-mode ultrasonography and MRI proton density fat fraction for fatty liver.Sci Rep. 2023 Sep 20;13(1):15557. doi: 10.1038/s41598-023-42422-5. Sci Rep. 2023. PMID: 37730972 Free PMC article.
-
Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents.J Pediatr Endocrinol Metab. 2020 Apr 28;33(4):473-479. doi: 10.1515/jpem-2019-0463. J Pediatr Endocrinol Metab. 2020. PMID: 32146441
-
Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.Eur Radiol. 2019 Jul;29(7):3564-3573. doi: 10.1007/s00330-019-06072-4. Epub 2019 Mar 21. Eur Radiol. 2019. PMID: 30899974 Review.
-
Accuracy of Ultrasonography vs. Elastography in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review.Cureus. 2022 Oct 6;14(10):e29967. doi: 10.7759/cureus.29967. eCollection 2022 Oct. Cureus. 2022. PMID: 36381908 Free PMC article. Review.
Cited by
-
No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study.Heliyon. 2024 Jun 11;10(12):e32827. doi: 10.1016/j.heliyon.2024.e32827. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 39183865 Free PMC article.
-
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?Endocrine. 2024 Sep;85(3):988-1006. doi: 10.1007/s12020-024-03783-7. Epub 2024 Mar 22. Endocrine. 2024. PMID: 38519764 Free PMC article. Review.
-
Correlation of Grades of Non-alcoholic Fatty Liver on Ultrasound With Blood Parameters.Cureus. 2024 Jan 27;16(1):e53075. doi: 10.7759/cureus.53075. eCollection 2024 Jan. Cureus. 2024. PMID: 38414673 Free PMC article.
-
Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.J Am Heart Assoc. 2024 Mar 5;13(5):e032604. doi: 10.1161/JAHA.123.032604. Epub 2024 Feb 23. J Am Heart Assoc. 2024. PMID: 38390843 Free PMC article.
-
Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study.Hepatol Int. 2024 Feb;18(1):138-154. doi: 10.1007/s12072-023-10576-z. Epub 2023 Sep 25. Hepatol Int. 2024. PMID: 37747618
References
-
- Mazhar SM, Shiehmorteza M, Sirlin CB. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009;7:135–40.
-
- Lee JY, Kim KM, Lee SG, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center. J Hepatol 2007;47:239–44.
-
- Ryan CK, Johnson LA, Germin BI, et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002;8:1114–22.
-
- Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis. Hepatology 2011;54:1082–90.
-
- Lee SS, Park SH, Kim HJ, et al. Non-invasive assessment of hepatic steatosis: Prospective comparison of the accuracy of imaging examinations. J Hepatol 2010;52:579–85.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
